These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24855130)

  • 1. Soft tissue augmentation with PMMA-microspheres for the treatment of HIV-associated buttock lipodystrophy.
    Serra MS; Gonçalves LZ; Ramos-e-Silva M
    Int J STD AIDS; 2015 Mar; 26(4):279-84. PubMed ID: 24855130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of facial lipoatrophy treatment with polymethyl methacrylate in AIDS patients as measured by four quality-of-life questionnaires.
    Warde M; Gragnani A; Gomes H; Hochman B; Ferreira LM
    Int J STD AIDS; 2011 Oct; 22(10):596-9. PubMed ID: 21998182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy.
    Burgess CM; Quiroga RM
    J Am Acad Dermatol; 2005 Feb; 52(2):233-9. PubMed ID: 15692467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone.
    Orentreich D; Leone AS
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):548-51. PubMed ID: 15056149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability.
    Silvers SL; Eviatar JA; Echavez MI; Pappas AL
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):34S-45S. PubMed ID: 16936543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel use of polymethyl methacrylate (PMMA) microspheres in the treatment of infraorbital rhytids.
    Mani N; McLeod J; Sauder MB; Sauder DN; Bothwell MR
    J Cosmet Dermatol; 2013 Dec; 12(4):275-80. PubMed ID: 24305426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoatrophy in patients with AIDS: treatment with polymethylmethacrylate in Amazonas, Brazil.
    Orsi AT; Miranda AE; Souza AC; Silva LC; Dias GR; Talhari C; Talhari S; Santos M
    Int J Dermatol; 2011 Oct; 50(10):1255-8. PubMed ID: 21950291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report.
    Parruti G; Toro GM
    BMC Infect Dis; 2005 Oct; 5():80. PubMed ID: 16202141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ribose-crosslinked collagen filler treatment for facial lipoatrophy associated with the treatment of human immunodeficiency virus.
    Reytan N; Rzany B
    J Drugs Dermatol; 2008 Dec; 7(12):1169-71. PubMed ID: 19137772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment.
    Reytan N; Rzany B
    J Drugs Dermatol; 2008 Sep; 7(9):884-6. PubMed ID: 19112805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of facial lipoatrophy with polymethylmethacrylate among patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): impact on the quality of life.
    Quintas RC; de França ER; de Petribú KC; Ximenes RA; Quintas LF; Cavalcanti EL; Kitamura MA; Magalhães KA; Paiva KC; Filho DB
    Int J Dermatol; 2014 Apr; 53(4):497-502. PubMed ID: 24602032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated lipodystrophy syndrome.
    Milinković A
    Coll Antropol; 2006 Dec; 30 Suppl 2():59-62. PubMed ID: 17508476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyacrylamide gel treatment of antiretroviral therapy-induced facial lipoatrophy in HIV patients.
    Mansor S; Breiting VB; Dahlstrøm K; Andersen AB; Andersen O; Christensen LH
    Aesthetic Plast Surg; 2011 Oct; 35(5):709-16. PubMed ID: 21359981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment methods for combination antiretroviral therapy-induced lipoatrophy of the face.
    Kadouch JA; van Rozelaar L; Karim RB; Hoekzema R
    Int J STD AIDS; 2013 Sep; 24(9):685-94. PubMed ID: 23970569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV facial lipoatrophy: causes and treatment options.
    Jones D
    Dermatol Surg; 2005 Nov; 31(11 Pt 2):1519-29; discussion 1529. PubMed ID: 16416634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gluteal Augmentation With Intramuscular Implants in Patients With Human Immunodeficiency Virus With Lipoatrophy Related to the Use of Antiretroviral Therapy.
    Andrade GA; Coltro PS; Barros ME; Müller Neto BF; Lima RV; Farina JA
    Ann Plast Surg; 2017 Nov; 79(5):426-429. PubMed ID: 28604545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of lipoatrophy and aging: volume deficits in the face.
    Coleman S; Saboeiro A; Sengelmann R
    Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents.
    Dollfus C; Blanche S; Trocme N; Funck-Brentano I; Bonnet F; Levan P
    HIV Med; 2009 May; 10(5):263-8. PubMed ID: 19178590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 39-year-old man with HIV-associated lipodystrophy.
    Fuller J
    JAMA; 2008 Sep; 300(9):1056-66. PubMed ID: 18677013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.